Tumour-associated protein carbonic anhydrase IX (CA IX) has two major forms. One is a cell-associated, transmembrane protein seen on Western blots as a twin band of 54/58 kDa, expressed in gastric mucosa and in several types of cancer. The other is a soluble protein s-CA IX of 50/54 kDa, which is released into the culture medium or into the body fluids, most likely by proteolytic cleavage of the extracellular part from transmembrane and intracellular sequences. While TC media of CA IX-positive tumour cell lines or short-term cultures of tumour explants contain a relatively high concentration of s-CA IX (20-50 ng ml(-1)), the level of this antigen in blood serum and urine of renal clear cell carcinoma patients is about 1000 x lower. The concentration of CA IX in the blood and in urine varies within wide limits and there is no obvious correlation with tumour size. After nephrectomy, s-CA IX is cleared from the blood within a few days. Only an extremely low concentration of CA IX was detectable in the sera and in urine of control individuals.

Institute of Molecular Genetics Academy of Sciences of the Czech Republic Flemingovo nám 2 16637 Prague Czech Republic

See more in PubMed

Chia SK, Wykoff CC, Watson PH, Han C, Leek RD, Pastorek J, Gatter KC, Ratcliffe P, Harris AL (2001) Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX (MN/CA IX), in invasive breast carcinoma. J Clin Oncol 19: 3660–3668 PubMed

Giatromanolaki A, Koukourakis MI, Sivridis E, Pastorek J, Wykoff CC, Gatter KC, Harris AL (2001) Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer. Cancer Res 61: 7992–7998 PubMed

Harris AL (2002) Hypoxia – a key regulatory factor in tumour growth. Nat Rev Cancer 2: 38–47 PubMed

Ivanov SV, Kuzmin I, Wei Ming-Hui, Pack S, Geil L, Johnson BE, Stanbridge EJ, Lerman MI (1998) Down-regulation of transmembrane carbonic anhydrases by wild-type von Hippel–Lindau transgenes. Proc Natl Acad Sci USA 95: 12596–12601 PubMed PMC

Koukorakis MI, Giatromanolaki A, Sivridis E, Simopoulos K, Pastorek J, Wykoff CC, Gatter KC, Harris AL (2001) Hypoxia-regulated carbonic anhydrase 9 (CA9) relates to poor vascularization and resistance of squamous cell head and neck cancer to chemotherapy. Clin Cancer Res 7: 3399–3403 PubMed

Liao SY, Aurelio ON, Jan K, Závada J, Stanbridge EJ (1997) Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney. Cancer Res 57: 2827–2831 PubMed

Liao SY, Brewer C, Závada J, Pastorek J, Pastoreková S, Manetta A, Berman ML, DiSaia PJ, Stanbridge EJ (1994) Identification of the MN antigen as a diagnostic biomarker of cervical intraepithelial squamous and glandular neoplasia and cervical carcinomas. Am J Pathol 145: 598–609 PubMed PMC

Opavský R, Pastoreková S, Zelník V, Gibadulinová A, Stanbridge EJ, Závada J, Kettmann R, Pastorek J (1996) Human MN/CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships. Genomics 33: 480–487 PubMed

Ortová-Gut M, Parkkila S, Vernerová Z, Rohde E, Závada J, Hocker M, Pastorek J, Karttunen T, Gibadulinová A, Závadová Z, Knobeloch K-P, Wiedenmann B, Svoboda J, Horak I, Pastoreková S (2002) Gastric hyperplasia in mice with targeted disruption of the carbonic anhydrase gene Car9. Gastroenterology 123: 1889–1903 PubMed

Pastoreková S, Závadová Z, Košt'ál M, Babušiková O, Závada J (1992) A novel quasi-viral agent, MaTu, is a two-component system. Virology 187: 620–626 PubMed

Saarnio J, Parkkila S, Parkkila AK, Haukipuro K, Pastoreková S, Pastorek J, Kairaluoma MI, Karttunen TJ (1998) Immunohistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN/CA IX, with potential value as a marker of cell proliferation. Am J Pathol 153: 279–285 PubMed PMC

Wingo T, Tu C, Laipis PJ, Silverman DN (2001) The catalytic properties of human carbonic anhydrase IX. Biochem Biophys Res Commun 288: 666–669 PubMed

Zat'ovičová M, Tarábková K, Švastová E, Gibadulinová A, Mucha V, Jakubičková L, Biesová Z, Ortova Gut M, Parkkila S, Parkkila A-K, Waheed A, Sly WS, Horak I, Pastorek J, Pastoreková S (2003) Monoclonal antibodies generated in CA IX-deficient mice recognize different domains of tumor-associated hypoxia-induced carbonic anhydrase IX. J Immunol Methods, (submitted) PubMed

Závada J, Závadová Z, Pastorek J, Biesová Z, Ježek J, Velek J (2000) Human tumour-associated cell adhesion protein MN/CA IX: Identification of M75 epitope and of the region mediating cell adhesion. Br J Cancer 82: 1808–1813 PubMed PMC

Závada J, Závadová Z, Pastoreková S, Čiampor F, Pastorek J, Zelník V (1993) Expression of MaTu-MN protein in human tumor cultures and in clinical specimens. Int J Cancer 54: 268–274 PubMed

Factors, associated with elevated concentration of soluble carbonic anhydrase IX in plasma of women with cervical dysplasia

DNA-linked Inhibitor Antibody Assay (DIANA) for sensitive and selective enzyme detection and inhibitor screening

Apoptosis-induced ectodomain shedding of hypoxia-regulated carbonic anhydrase IX from tumor cells: a double-edged response to chemotherapy